Javascript must be enabled to continue!
Vitamin D plasma concentration and VDR gene polymorphisms in patients with non-dipper hypertension
View through CrossRef
Abstract
The study of the effects of vitamin D today has a high interest in the scientific community.
We determined the plasma level of vitamin D and the polymorphisms of the vitamin D receptor gene (VDR rs1544410, VDR rs2228570) in patients with non-dipper hypertension.
In our clinic, we examined 160 patients aged 30–60, among which a group of hypertensive patients with dipper status included 52 people, a group of hypertensive patients with non-dipper status - 53 people, a control group of 55 people without hypertention, correlating in gender and age with study groups.
The 25 OH vitamin D level was lower in the hypertension groups, both dipper status - 20.5 (14.0; 23.3) ng / ml and non-dipper status 15.0 (12.0; 18.0) ng / ml compared with the control group - 26.0 (19.5; 30.5) ng / ml, p=0.003 and p<0.001.
The results of genotyping showed the presence of genetic features in hypertensive patients with non-dipper status compared with the hypertensive patients with dipper status and the control group at the rs2228570 locus of the VDR gene, p<0.001. The total frequency of genotypes in the following groups: in the non-dipper group the G / A genotype accounts for 49.1% (26), A/A – 41.5% (22), G/G – 9.4% (5); in the dipper group the G/A genotype was 65.4% (34), A/A – 19.2% (10), G/G – 15.4% (8); in the control group G/A – 47.3% (26), A/A – 10.9% (6), G/G – 41.8% (23) for rs2228570 of the VDR gene. Statistical differences from the dipper group and the control group were not obtained in rs1544410 of the VDR gene.
Further studies are needed to clarify the association between rs2228570 of the VDR gene, vitamin D levels and non-dipper status in hypertension.
Funding Acknowledgement
Type of funding source: None
Oxford University Press (OUP)
Title: Vitamin D plasma concentration and VDR gene polymorphisms in patients with non-dipper hypertension
Description:
Abstract
The study of the effects of vitamin D today has a high interest in the scientific community.
We determined the plasma level of vitamin D and the polymorphisms of the vitamin D receptor gene (VDR rs1544410, VDR rs2228570) in patients with non-dipper hypertension.
In our clinic, we examined 160 patients aged 30–60, among which a group of hypertensive patients with dipper status included 52 people, a group of hypertensive patients with non-dipper status - 53 people, a control group of 55 people without hypertention, correlating in gender and age with study groups.
The 25 OH vitamin D level was lower in the hypertension groups, both dipper status - 20.
5 (14.
0; 23.
3) ng / ml and non-dipper status 15.
0 (12.
0; 18.
0) ng / ml compared with the control group - 26.
0 (19.
5; 30.
5) ng / ml, p=0.
003 and p<0.
001.
The results of genotyping showed the presence of genetic features in hypertensive patients with non-dipper status compared with the hypertensive patients with dipper status and the control group at the rs2228570 locus of the VDR gene, p<0.
001.
The total frequency of genotypes in the following groups: in the non-dipper group the G / A genotype accounts for 49.
1% (26), A/A – 41.
5% (22), G/G – 9.
4% (5); in the dipper group the G/A genotype was 65.
4% (34), A/A – 19.
2% (10), G/G – 15.
4% (8); in the control group G/A – 47.
3% (26), A/A – 10.
9% (6), G/G – 41.
8% (23) for rs2228570 of the VDR gene.
Statistical differences from the dipper group and the control group were not obtained in rs1544410 of the VDR gene.
Further studies are needed to clarify the association between rs2228570 of the VDR gene, vitamin D levels and non-dipper status in hypertension.
Funding Acknowledgement
Type of funding source: None.
Related Results
Variants of the vitamin D receptor gene and the expression of microRNA‑21, microRNA‑125a, microRNA‑125b and microRNA‑214 in coronary heart disease
Variants of the vitamin D receptor gene and the expression of microRNA‑21, microRNA‑125a, microRNA‑125b and microRNA‑214 in coronary heart disease
Background. The protective effects of vitamin D in relation to atherogenesis are realized by vitamin D receptors (VDR). Variants rs10735810, rs731236, rs1544410 and rs797532 of the...
Pecularities of the ischemic heart disease clinical course in patients with different provision of vitamin D, residents of St. Petersburg: an association with a complex of genotypes of vitamin D receptor
Pecularities of the ischemic heart disease clinical course in patients with different provision of vitamin D, residents of St. Petersburg: an association with a complex of genotypes of vitamin D receptor
Background. Vitamin D has been shown to reduce the risk of atherosclerosis development. Vitamin D receptors (VDRs) mediate the protective effects of vitamin D on immune inflammatio...
P021 Vitamin D receptor-dependent protective effect of moderate hypoxia in a mouse colitis model Running title: Hypoxia prevents mouse colitis through VDR
P021 Vitamin D receptor-dependent protective effect of moderate hypoxia in a mouse colitis model Running title: Hypoxia prevents mouse colitis through VDR
Abstract
Background
Although physiological hypoxia is important for maintaining the intestinal barrier, its effect on the barrie...
Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease
Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease
AbstractLarge numbers of statistically significant associations between sentinel SNPs and case-control status have been replicated by genome-wide association studies. Nevertheless,...
Vitamin D and the Immune System. When? Why? How?
Vitamin D and the Immune System. When? Why? How?
Vitamin D, called “the sunshine vitamin” is essential for the good functioning of the human body. Vitamin D generates its principal effects via the vitamin D receptor (VDR), a spec...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
RISK CONFERRED BY POLYMORPHIC VARIANTS OF VITAMIN D RECEPTOR (VDR) AND ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENES FOR ESSENTIAL HYPERTENSION
RISK CONFERRED BY POLYMORPHIC VARIANTS OF VITAMIN D RECEPTOR (VDR) AND ANGIOTENSIN II TYPE 1 RECEPTOR (AGTR1) GENES FOR ESSENTIAL HYPERTENSION
Objective:
The aim of this study was to establish the role of 1166A>C polymorphism of the AGTR1 gene (rs5186) and A/G polymorphism of the VDR gene (rs2228570) in ris...

